Technical Analysis for QURE - uniQure N.V.

Grade Last Price % Change Price Change
grade A 25.53 -1.39% -0.36
QURE closed down 1.39 percent on Friday, February 23, 2018, on 76 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
6 Watchers
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical QURE trend table...

Date Alert Name Type % Chg
Feb 23 Slingshot Bullish Bullish Swing Setup 0.00%
Feb 23 Spinning Top Other 0.00%
Feb 23 Upper Bollinger Band Walk Strength 0.00%
Feb 23 Wide Bands Range Expansion 0.00%
Feb 23 Overbought Stochastic Strength 0.00%
Feb 22 New 52 Week Closing High Bullish -1.39%
Feb 22 New 52 Week High Strength -1.39%
Feb 22 Upper Bollinger Band Walk Strength -1.39%
Feb 22 Wide Bands Range Expansion -1.39%
Feb 22 Overbought Stochastic Strength -1.39%

Older signals for QURE ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
uniQure BV, a biopharmaceutical company, develops gene therapies through its modular technology platform for the treatment of genetic or acquired diseases. The company offers Glybera for the treatment of patients with lipoprotein lipase deficiency, an orphan metabolic disease. It also develops a pipeline of additional adeno-associated virus (AAV) based gene therapies, including AMT-060, a gene therapy for the treatment of hemophilia B; AMT-021 for acute intermittent porphyria; AMT-110 for Sanfilippo B syndrome; and AAV2/glial cell line-derived neurotrophic factor for Parkinson's disease, as well as various programs that are in early preclinical development stage. The company has collaborations with Chiesi Farmaceutici S.p.A., Digna Biotech, Institut Pasteur, and University of California San Francisco. uniQure BV was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Is QURE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 26.75
52 Week Low 4.72
Average Volume 410,516
200-Day Moving Average 12.0817
50-Day Moving Average 19.7134
20-Day Moving Average 21.3695
10-Day Moving Average 23.861
Average True Range 1.465
ADX 31.12
+DI 31.06
-DI 10.34
Chandelier Exit (Long, 3 ATRs ) 22.355
Chandelier Exit (Short, 3 ATRs ) 21.835
Upper Bollinger Band 27.1182
Lower Bollinger Band 15.6208
Percent B (%b) 0.86
BandWidth 53.80285
MACD Line 1.85
MACD Signal Line 1.3454
MACD Histogram 0.5046
Fundamentals Value
Market Cap 652.54 Million
Num Shares 25.6 Million
EPS -2.82
Price-to-Earnings (P/E) Ratio -9.05
Price-to-Sales 16.30
Price-to-Book 14.70
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 27.41
Resistance 3 (R3) 27.45 26.88 27.09
Resistance 2 (R2) 26.88 26.40 26.85 26.99
Resistance 1 (R1) 26.20 26.10 25.92 26.16 26.88
Pivot Point 25.63 25.63 25.48 25.60 25.63
Support 1 (S1) 24.95 25.15 24.67 24.91 24.18
Support 2 (S2) 24.38 24.85 24.35 24.07
Support 3 (S3) 23.70 24.38 23.97
Support 4 (S4) 23.66